Listed
Stock Code: 950160
| Company Name | 코오롱티슈진(주) |
| English Name | Kolon TissueGene, Inc. |
| Business Reg. No. | 20174063267 |
| CEO | 노문종, 전승호 |
| Address | Rockville, MD, USA 9713 Key West Ave Suite 300 |
| Industry | 기초 의약 물질 및 생물학적 제제 제조업 |
| Industry Code | 211 |
| Established | 19990609 |
| Phone | 1-301-921-6000 |
| Website | tissuegene.com |
| Regular Employees | 58persons |
| Corp. Reg. No. | Contact |
Revenue CAGR +2.1%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 0.0B | 0.0B | 0.1B | 0.0B |
| Operating Profit | -0.2B | -0.2B | -0.1B | -0.4B |
| Net Profit | -0.2B | -0.1B | -0.1B | -0.4B |
| Total Assets | 1.5B | 1.0B | 0.9B | 0.5B |
| Total Liabilities | 0.5B | 0.2B | 0.1B | 0.2B |
| Total Equity | 1.0B | 0.9B | 0.7B | 0.3B |
Operating Loss: Op. profit -1,61310K
4 Consecutive Years of Net Loss
Debt Ratio Surge (+35pp YoY)
▼ 18.3%
▲ 30.2%
▲ 31.4%
▲ 63.0%
▲ 51.3%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 노문종 | 사내이사 | 경영 총괄 (CEO) | - |
| 박건영 | 미등기 | 운영책임자 (COO) | - |
| 전승호 | 사내이사 | 경영 총괄 (CEO) | - |
| 김정인 | 사내이사 | 재무책임자 (CFO) | - |
| 이선주 | 사외이사 | 사외이사 | - |
| Young J. Kim | 감사 | 감사 | - |
| 권순욱 | 미등기 | 한국 지점장 | - |
| Charles Nye | 미등기 | Manufac -turing 총괄 | - |
| 김선진 | 미등기 | 임상총괄 (CMO) | - |
| Diana Halim | 미등기 | Clinical Operations & Regulatory Affairs | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 17persons |
| CEO | 노문종, 전승호 |
| Est. Avg. Annual Salary | 5,74710K (47910K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2017-08-01 |
1 Additional Data Sources
{
"address": "경기도 과천시 코오롱로",
"brno": "301840****",
"cappedWarning": false,
"companyName": "코오롱티슈진(주)한국지점",
"estimatedAvgAnnualSalary": 57467736,
"estimatedAvgMonthlySalary": 4788978,
"fetchedAt": "2026-03-05T11:08:16.981Z",
"industryCode": "515080",
"industryName": "의료 기기 도매업",
"joinDate": "20170801",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 7734200,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6483171",
"status": "1",
"styleCode": "1",
"subscriberCount": 17,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 6/7
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Patents | KIPRIS | Collected |
| Procurement | Not Collected | Not Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |